BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9130647)

  • 1. Chemoattractant receptors for interleukin-8 and C5a: expression on peripheral blood leukocytes and differential regulation on HL-60 and AML-193 cells by vitamin D3 and all-trans retinoic acid.
    Zahn S; Zwirner J; Spengler HP; Götze O
    Eur J Immunol; 1997 Apr; 27(4):935-40. PubMed ID: 9130647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor.
    Chuntharapai A; Kim KJ
    J Immunol; 1995 Sep; 155(5):2587-94. PubMed ID: 7650389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-8 and NAP-2 differ in their capacities to bind and chemoattract 293 cells transfected with either IL-8 receptor type A or type B.
    Ben-Baruch A; Bengali K; Tani K; Xu L; Oppenheim JJ; Wang JM
    Cytokine; 1997 Jan; 9(1):37-45. PubMed ID: 9067094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of monocyte chemoattractant protein-1 and interleukin-8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential.
    Qin S; LaRosa G; Campbell JJ; Smith-Heath H; Kassam N; Shi X; Zeng L; Buthcher EC; Mackay CR
    Eur J Immunol; 1996 Mar; 26(3):640-7. PubMed ID: 8605932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation.
    Sabroe I; Williams TJ; Hébert CA; Collins PD
    J Immunol; 1997 Feb; 158(3):1361-9. PubMed ID: 9013980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interleukin-8 receptor B and CXC chemokines can mediate transendothelial migration of human skin homing T cells.
    Santamaria Babi LF; Moser B; Perez Soler MT; Moser R; Loetscher P; Villiger B; Blaser K; Hauser C
    Eur J Immunol; 1996 Sep; 26(9):2056-61. PubMed ID: 8814246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-gamma up-regulates the human C5a receptor (CD88) in myeloblastic U937 cells and related cell lines.
    Burg M; Martin U; Rheinheimer C; Köhl J; Bautsch W; Böttger EC; Klos A
    J Immunol; 1995 Nov; 155(9):4419-26. PubMed ID: 7594603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
    Tardif M; Brouchon L; Rabiet MJ; Boulay F
    Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C5a receptor and interleukin-6 are expressed in tissue macrophages and stimulated keratinocytes but not in pulmonary and intestinal epithelial cells.
    Fayyazi A; Sandau R; Duong LQ; Götze O; Radzun HJ; Schweyer S; Soruri A; Zwirner J
    Am J Pathol; 1999 Feb; 154(2):495-501. PubMed ID: 10027407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes.
    Chuntharapai A; Lee J; Hébert CA; Kim KJ
    J Immunol; 1994 Dec; 153(12):5682-8. PubMed ID: 7527448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization.
    Bock D; Martin U; Gärtner S; Rheinheimer C; Raffetseder U; Arseniev L; Barker MD; Monk PN; Bautsch W; Köhl J; Klos A
    Eur J Immunol; 1997 Jun; 27(6):1522-9. PubMed ID: 9209506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against the N-terminus of IL-8 receptor A inhibit neutrophil chemotaxis.
    Quan JM; Martin TR; Rosenberg GB; Foster DC; Whitmore T; Goodman RB
    Biochem Biophys Res Commun; 1996 Feb; 219(2):405-11. PubMed ID: 8605000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue.
    Miller LJ; Kurtzman SH; Wang Y; Anderson KH; Lindquist RR; Kreutzer DL
    Anticancer Res; 1998; 18(1A):77-81. PubMed ID: 9568059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C5a, interleukin-8 and tumour necrosis factor-alpha-induced changes in granulocyte and monocyte expression of complement receptors in whole blood and on isolated leukocytes.
    Furebring M; Håkansson L; Venge P; Sjölin J
    Scand J Immunol; 2006 Mar; 63(3):208-16. PubMed ID: 16499574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells.
    Tardif M; Mery L; Brouchon L; Boulay F
    J Immunol; 1993 Apr; 150(8 Pt 1):3534-45. PubMed ID: 8468487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of the C3a and C5a receptors (CD88) by IFN-gamma and PMA in U937 cells and related myeloblastic cell lines.
    Burg M; Martin U; Bock D; Rheinheimer C; Köhl J; Bautsch W; Klos A
    J Immunol; 1996 Dec; 157(12):5574-81. PubMed ID: 8955209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct.
    Ahuja SK; Lee JC; Murphy PM
    J Biol Chem; 1996 Jan; 271(1):225-32. PubMed ID: 8550564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined vitamin D3/retinoic acid induction of human promyelocytic cell lines: enhanced phagocytic cell maturation and hybrid granulomonocytic phenotype.
    Masciulli R; Testa U; Barberi T; Samoggia P; Tritarelli E; Pustorino R; Mastroberardino G; Camagna A; Peschle C
    Cell Growth Differ; 1995 May; 6(5):493-503. PubMed ID: 7647032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
    Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
    Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
    Oppermann M; Götze O
    Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.